The Role of Interleukin-17 in Heart and Vascular Diseases at Thi-Qar Governorate

Authors

  • Department of Biology, College of education of pure science, University of Thi-Qar, Thi-Qar, Iraq
  • Department of Biology, College of education of pure science, University of Thi-Qar, Thi-Qar, Iraq

DOI:

https://doi.org/10.32792/jeps.v13i4.372

Keywords:

Heart and Vascular diseases, IL-17, smoking.

Abstract

Abstract:
The objective of this study is to assess Interleukin-17 in cardiovascular patients. This study was conducted in the heart center in Thi-Qar Governorate, during the period between1/12/2023 to 1/4/2024. The study was investigated to measure Interleukin-17 (IL-17) levels in the serum using Enzyme-Linked Immunosorbent Assay (ELISA). The study included 100 participants: 50 patients with heart and vascular diseases and 50 healthy subjects serving as controls. The statistical analysis showed a significant increase in serum the mean concentration of (IL-17) in patients (10.90±4.28) pg/ml compared to the healthy control group (8.108±3.72) pg/ml with a statistically significant difference (P=0.001). So, it is concluded that the high level of IL-17 in the serum has to do with cardiovascular diseases.

References

M. Fakhry and A. Al-Aseel S. Worthan, “Prevention of cardiovascular disease. King Fahd University Hospital in Al-Khobar”. University of Dammam. 2017.

M. Veldhoen, Interleukin 17 is a chief orchestrator of immunity. Nature Immunology. Vol.18, pp. 612–621. 2017.

X. Zhang and F. Pei M. Zhang C. Yan M. Huang T. Wang Y. Han, “Interleukin-17A gene variants and risk of coronary artery disease: A large angiography-based study”. Clinica Chimica Acta 412, pp. 327–331. 2011.

G. Allam and A. Abdel-Moneim A. Gaber, “The pleiotropic role of interleukin-17 in atherosclerosis”. Biomedicine &Pharmacotherapy journal. 106. Pp.1412–1418. 2018.

E. Attia and A. Salman, “The Role of CXCR3 in Cardiovascular Disease Patients in Thi-Qar Province, Iraq”. NeuroQuantology: pp.211-214. 2022.

A. Csiszar and Z. Ungvari, “Synergistic effects of vascular IL-17 and TNFa may promote coronary artery disease”. Medical Hypotheses. 63, pp. 696–698. 2004.

S. Zhou and J. Yuan M. Liao N. Xia T. Tang J. Li J. Jiao W. Dong S. Nie Z. Zhu W. Zhang B. Lv H. Xiao Q. Wang X. Tu Y. Liao G. Shi X. Cheng, “IL-17A promotes ventricular remodeling after myocardial infarction,” J Mol Med. 92: pp.1105–1116. 2014.

M. Mora-Ruíz and F. Blanco-Favela A. Rueda M. Legorreta-Haquet L. Chávez-Sánchez, “Role of interleukin-17 in acute myocardial infarction”. Molecular Immunology 107. Pp. 71–78. 2019.

H. Wada and M. Nakamura S. Inoue K. Kudo T. Hanawa Y. Iwakura F. Kobayashi H. Kamma S. Kamiya K. Ito P. Barnes H. Takizawa, “Dual interleukin‑17A/F deficiency protects against acute and chronic responses to cigarette smoke exposure in mice”. Scientific Reports 11:11508. 2021.

T. Simon and S. Taleb N. Danchin L. Laurans B. Rousseau S. Cattan J. Montely O. Dubourg A. Tedgui S. Kotti Z. Mallat, “Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction”. European Heart Journal .34, pp.570–577. 2013.

Downloads

Published

2023-12-03

Issue

Vol. 13 No. 4 (2023): JOURNAL OF COLLEGE OF EDUCATION FOR PURE SCIENCES

Section

Articles

License

Copyright (c) 2023 Journal of Education for Pure Science- University of Thi-Qar

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright Policy

Authors retain copyright of their articles published in the Journal of Education for Pure Science (JEPS).

By submitting their work, authors grant the journal a non-exclusive license to publish, distribute, and archive the article in all formats and media.

License

All articles published in JEPS are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

This license permits unrestricted use, distribution, and reproduction in any medium, provided that the original author(s) and the source are properly credited.

Author Rights

Authors have the right to:

  • Share their articles on personal websites, institutional repositories, and academic platforms

  • Reuse their work in future research and publications

  • Distribute the published version without restriction

Journal Rights

The journal retains the right to:

  • Publish and archive the articles

  • Include them in indexing and archiving systems such as LOCKSS and CLOCKSS

  • Promote and disseminate the published work

Responsibility

The contents of all articles are the sole responsibility of the authors. The journal, editors, and editorial board are not responsible for any errors, opinions, or statements expressed in the published articles.

Open Access Statement

JEPS provides immediate open access to its content, supporting the principle that making research freely available to the public enhances global knowledge exchange.

This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0/